MEDIA RELEASE FOR IMMEDIATE RELEASE

GROUNDBREAKING OF PARKWAY YANGON HOSPITAL MARKS IHH HEALTHCARE’S FIRST FORAY INTO MYANMAR

• Joint venture consortium to invest US$70 million in a 250-bed hospital in Yangon • Exchange of medical knowledge and clinical practices to support Myanmar’s Health Vision 2030 • Access to international healthcare standards for people of Myanmar

YANGON, 24 JANUARY 2016 – IHH Healthcare Berhad (“IHH” or the “Group”), through its

indirect wholly-owned subsidiary, Parkway Healthcare Indo- Pte Ltd, today broke ground for a US$70-million, 250-bed hospital in Yangon, Myanmar. The new hospital,

Parkway Yangon, is Parkway Pantai’s first hospital in Myanmar and represents a continuation of its trans-boundary expansion in providing superior clinical care and outcomes in regional markets where the demand for quality healthcare is growing.

The project will be developed and operated by a joint venture consortium, Andaman Alliance

Healthcare Limited (“AAHL”), comprising Parkway Healthcare Indo-China Pte. Ltd. with a

52.0% stake, -incorporated Macondray Holdings Pte Ltd with 10.5%, Myanmar- incorporated AMMK Medicare Company Limited with 21.5%, and Myanmar-incorporated

Global Star Company Limited with the remaining 16%. The hospital is located at downtown

Yangon on a 4.3 acres plot of land leased for 50 years at prevailing market rate, with the option of two 10-year extensions. This represents a significant commitment to invest in the local community through a “build-operate-transfer” model. Investment for the project has obtained approval from the Myanmar Investment Commission.

The ground-breaking ceremony of Parkway Yangon was graced by H.E. U Myint Swe, Chief

Minister for Yangon Region and H.E. Dr Than Aung, Minister for Health.

Dr Tan See Leng, Managing Director & Chief Executive Officer of IHH and Group Chief

Executive Officer & Managing Director of Parkway Pantai, said, “This exciting joint

venture will bring high-quality healthcare to the people of Myanmar when it opens in 2020.

We believe this hospital will greatly support Myanmar’s national health policy, Health Vision

2030, which aims to deliver world-class healthcare outcomes, research and services, and improve the health of the citizens of Myanmar. Leveraging our more than 40 years’ experience in operating premium hospitals across 9 countries, we are committed to working closely with the local Ministry of Health and our business partners to help achieve this noble vision and elevate national healthcare standards in Myanmar.”

The establishment of Parkway Yangon will be a catalyst for the training of healthcare professionals such as nurses and allied healthcare practitioners. This will create more job opportunities for the community. The integration into the healthcare ecosystem will also stimulate the transfer of knowledge, sharing of best clinical practices and levelling of medical expertise.

The new hospital will be a boost to ongoing efforts in uplifting medical services to world-class standards. This will provide an alternative for the many citizens who currently travel out of the country each year for healthcare.

Doctors from , one of the key hospitals under the Parkway Pantai network, have been actively engaging with specialists in Myanmar in various community outreach initiatives like exchange of medical expertise and outreach to the masses through disease prevention and health promotion activities. The presence of Parkway Yangon will further these corporate social responsibility efforts to include partnerships with training colleges, scholarships, and overseas training fellowships for local Myanmese.

Page 2 of 4

“I am confident that this hospital project will raise the healthcare standards of Myanmar and benefit our people. It will also boost the Myanmar economy as it will bring about huge investments in infrastructure and technology. Our people will have access to a standard of care comparable to international hospitals in the region without leaving the country,” said U

Aung Moe Kyaw, Director of AMMK Medicare Company Limited.

As the Myanmar government takes steps to improve healthcare infrastructure and expand basic health coverage, demand for private health services in the country is expected to rise.

Myanmar's long-term income growth potential and gradual emergence of a middle class, coupled with the rapid influx of foreign tourists and expatriates, are expected to bode well for private healthcare providers like IHH.

END

For further information or to speak to an IHH or Parkway Pantai spokesperson, please contact:

Matthew Loh Janet Low Josephine Chew t. +65 9170 2541 t. +65 9017 8094 t. +65 9061 0353 e. [email protected] e. [email protected] e. josephine.chew@watatawa.

Page 3 of 4

About IHH Healthcare Berhad (“IHH”) IHH Healthcare Berhad is a leading premium healthcare provider in markets where the demand for quality care is strong and growing. We are the second largest healthcare group in the world by market capitalisation and are listed on the Main Market of Bursa and the Main Board of SGX-ST.

Employing more than 25,000 people and operating close to 10,000 licensed beds across 49 hospitals in 9 countries worldwide, the Group offers the full spectrum of integrated healthcare services from clinics to hospitals to quaternary care and a wide range of ancillary services across our three operating subsidiaries:

• Parkway Pantai Limited is one of Asia's largest integrated private healthcare groups with a network of 31 hospitals and more than 6,000 licensed beds throughout the region, including Singapore, Malaysia, , China, and UAE. Its “Mount Elizabeth”, “Gleneagles”, “Parkway” and “Pantai” brands are among the most prestigious in Asia. • Acibadem Holdings is Turkey’s largest private healthcare provider by registered beds, offering integrated healthcare services across 18 hospitals in Turkey, Macedonia and Iraq. The “Acibadem” brand is renowned for its clinical excellence in the Central & Eastern Europe, Middle East and North Africa (“CEEMENA”) region. • IMU Health is IHH’s medical education arm, and oversees the established higher learning institutions of International Medical College (“IMC”) and International Medical University (“IMU”) in Malaysia.

IHH is the leading player in our home markets of Malaysia, Singapore and Turkey, and key growth markets of China, and India. For more information, please visit www.ihhhealthcare.com.

About Parkway Pantai Limited (“Parkway Pantai”) Parkway Pantai Limited, part of IHH Healthcare Berhad, is one of the region's largest integrated private healthcare groups with a network of 31 hospitals and more than 6,000 licensed beds throughout Asia, including Singapore, Malaysia, India, China, Brunei and . By 2017, Parkway Pantai will have about 1,800 additional beds from opening two new hospitals and expanding capacity in its existing hospitals.

In Singapore, the Group operates a suite of Singapore's premier private hospitals: Mount Elizabeth Novena Hospital, Mount Elizabeth Hospital, and - all accredited by Joint Commission International (JCI). It also owns Parkway Shenton, a large network of primary healthcare clinics and services, ParkwayHealth Radiology, ParkwayHealth Laboratory and Parkway College.

In Malaysia, the Group owns and operates ten Pantai Hospitals, four Gleneagles Hospitals and ancillary healthcare services including Pantai Integrated Rehab and Pantai Premier Pathology.

Parkway Pantai Limited also operates more than 20 patient assistance centres across the globe, providing patients with seamless patient care and a one-stop referral source to its hospitals and services. For more information, please visit the website at www.parkwaypantai.com.

Page 4 of 4